Observe Medical ASA - Received Innovation Norway Loan Commitment of NOK 15 million
Oslo, 19 December 2025 - Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSRV") has received a loan commitment from Innovation Norway for a loan of NOK 15 million to support the continued commercialisation of the Company's UnoMeter™ product portfolio, and commercial preparation for the launch of Sippi®.
The availability of the loan is subject to execution of final loan documentation and certain customary conditions precedent.
Further information regarding final terms and drawdown will be provided once the loan agreement has been executed.
Jørgen Mann, CEO of Observe Medical, commented: "We consider the loan commitment from Innovation Norway to be an important milestone for Observe Medical. During 2025, the Company completed equity financings raising gross proceeds of NOK 58.5 million, and in combination with the loan from Innovation Norway we are now able increase the speed and momentum in the ongoing commercialisation of the UnoMeter™ portfolio including the rollout of the defined product pipeline. Furthermore, it will allow us to take steps to implement our full corporate strategy to be a partner for the Nordic innovative ecosystem within the Medtech area"
This information is considered to constitute inside information pursuant to the EU Market Abuse Regulation and is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This announcement was published by Johan Fagerli, CFO, on 19. December 2025 at 15:30 CET
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.